1. Home
  2. TASK vs CABA Comparison

TASK vs CABA Comparison

Compare TASK & CABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TaskUs Inc.

TASK

TaskUs Inc.

HOLD

Current Price

$5.08

Market Cap

544.9M

Sector

Technology

ML Signal

HOLD

Logo Cabaletta Bio Inc.

CABA

Cabaletta Bio Inc.

HOLD

Current Price

$3.13

Market Cap

495.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TASK
CABA
Founded
2008
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
544.9M
495.7M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
TASK
CABA
Price
$5.08
$3.13
Analyst Decision
Hold
Strong Buy
Analyst Count
5
6
Target Price
$14.70
$14.50
AVG Volume (30 Days)
617.9K
5.6M
Earning Date
05-06-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
120.00
10.26
EPS
0.26
N/A
Revenue
N/A
N/A
Revenue This Year
$5.95
N/A
Revenue Next Year
$6.46
N/A
P/E Ratio
$19.35
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.47
$1.26
52 Week High
$18.39
$4.23

Technical Indicators

Market Signals
Indicator
TASK
CABA
Relative Strength Index (RSI) 42.57 51.38
Support Level $4.47 $3.12
Resistance Level $6.62 $3.34
Average True Range (ATR) 0.30 0.21
MACD 0.03 0.03
Stochastic Oscillator 46.32 82.35

Price Performance

Historical Comparison
TASK
CABA

About TASK TaskUs Inc.

TaskUs Inc provides outsourced digital services. Its service offerings include Digital Customer Experience consists of omnichannel customer care services, delivered through digital (non-voice) channels, also including learning experience and sales and customer acquisition services; Trust & Safety consists of monitoring, reviewing and managing user and advertiser-generated content on online platforms to ensure it complies with community guidelines, legal regulations and platform specific policies; and AI Services consists of large language model support and high-quality data labeling services, annotation, context relevance and transcription services performed for the purpose of training and tuning machine learning algorithms, enabling them to develop cutting-edge AI systems.

About CABA Cabaletta Bio Inc.

Cabaletta Bio Inc is a late clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for autoimmune diseases. Its proprietary Cabaletta Approach to B cell Ablation (CABA) platform includes the CARTA approach, which uses chimeric antigen receptor T cells to eliminate B cells and potentially reset the immune system. The company develops cellular therapies including CAR T and CAAR T product candidates. Its candidate, rese-cel (resecabtagene autoleucel), a CD19-CAR T cell therapy, is being evaluated in Phase 1/2 trials for autoimmune diseases such as systemic lupus erythematosus, myositis, systemic sclerosis, generalized myasthenia gravis, and pemphigus vulgaris.

Share on Social Networks: